Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plants of Ruskin is a Florida-based medical cannabis company that operates as a vertically integrated Medical Marijuana Treatment Center (MMTC). The company holds one of the original licenses in Florida and operates under the MÜV brand following its integration with AltMed and subsequent acquisition by Verano Holdings. Its operations include large-scale cultivation, state-of-the-art extraction and manufacturing facilities, and a network of retail dispensaries across the state. The company focuses on providing high-quality, pharmaceutical-grade cannabis products, including flower, concentrates, topicals, and transdermal patches, to registered patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plants of Ruskin.